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Cell-Autonomous Defects in Dendritic Cell Populations
of Ikaros Mutant Mice Point to a Developmental
Relationship with the Lymphoid Lineage
(Georgopoulos et al., 1994; Wang et al., 1996). These
studies on the Ikaros dominant-negative and null mice
indicate that the Ikaros gene family plays a crucial role
during the differentiation of primitive hemopoietic pro-
genitors toward the lymphoid lineages. The Ikaros mu-
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tant mice therefore provide useful models for studyingAustralia
differentiation along lymphoid-related lineages.²Cutaneous Biology Research Center
Dendritic cells (DCs) are ªprofessionalº antigen-pre-Massachusetts General Hospital
senting cells, essential for initiating T cell immune re-Harvard Medical School
sponses. Studies on bone marrow and blood cell cul-Charlestown, Massachusetts 02129
tures have convincingly demonstrated that DCs can be
generated from myeloid progenitors and that granulo-
cyte/macrophage colony-stimulating factor (GM-CSF) isSummary
an essential cytokine for such development. DCs are
generally believed to be of myeloid origin (Caux andThe transcription factor Ikaros is a major determinant
Banchereau, 1996; Inaba et al., 1992; Young et al., 1995).of lymphocyte differentiation. Mice homozygous for
However, our recent studies have shown that almost allan Ikaros dominat-negative (DN2/2) mutation lack all
thymic DCs are generated within the thymus from ancells of lymphoid origin, including T, B, and natural
early intrathymic precursor population (the so-called lowkiller (NK) cells. Mice homozygous for an Ikaros null
CD4 precursors), which can also produce T, B, and NKallele lack B and NK cells but display specific defects
cells, but not cells of the erythroid and myeloid lineagein T lymphocytes. Nonetheless, both Ikaros mutant lines
(Wu et al., 1991a, 1991b, 1995, 1996; Ardavin et al.,make an excess of monocytes and macrophages. Here
1993; Matsuzaki et al., 1993). Therefore, thymic DCs thatwe report that the production of subsets of antigen-
develop in parallel with T cells in the thymus may derivepresenting dendritic cells (DCs) is also defective. By
from the same precursor population (Wu et al., 1995).constructing bone marrow chimeras, we demonstrate
It was further demonstrated that the so-called pro-Tthat the Ikaros-mediated defect in lymphocytes and
precursors (CD324282c-kit1CD251), which lie a stepDCs is intrinsic to their precursors and is not environ-
downstream of the low CD4 progenitors in the T cellment dependent. The selective defects in DCs mani-
developmental pathway and are no longer able to gener-fested with the Ikaros null mutation suggest a tight
ate B and NK cells, are still capable of generating DCs
linkage between development of T cells and CD8a1
(Godfrey et al., 1993; Moore and Zlotnik, 1995; ZuÂ nÄ iga-
DCs. The complete lack of DCs in the lymphoid organs
PfluÈ ckeret al., 1995; Wu etal., 1996). More recent studiesof Ikaros DN2/2 micke points to an essential role for
have also shown that DCs can be generated in culturethe Ikaros gene family in the development of all DCs.
from the intrathymic precursor populations by using a
combination of cytokines that does not include GM-CSF
Introduction (Saunders et al., 1996). These data argue that, unlike
other DCs, development of thymic DCs is closely associ-
Ikaros is a member of a family of early hemopoietic- and ated with the development of the T lineage.
lymphoid-restricted zinc-finger DNA-binding proteins If all or most thymic DCs are considered to be related
with distinct functions in transcription (Georgopoulos et to the lymphoid rather than to the myeloid lineage, we
al., 1992; Molnar et al., 1996; Hahm et al., 1994; Sun et must ask whether any of the DCs in peripheral lymphoid
al., 1996; Morgan et al., 1997, and B. Morgan, personal organs are likewise lymphoid related. Indeed, we have
communication). Recent studies have shown that mice shown that a subpopulation of the DCs in the spleen
homozygous for a dominant-negative mutation in the and the lymph nodes (LNs) are similar to thymic DCs
Ikaros gene (DN2/2, DNA-binding domain deletion) have in bearing certain lymphoid markers, notably a CD8aa
a profound deficiency in the development of all T and homodimer (Vremec et al., 1992; Vremec and Shortman,
B lymphocytes and natural killer (NK) cells in both the 1997; Wu et al., 1995). We have also shown that thymic
fetal and adult hemopoietic compartment (Georgo- precursors are capable of generating these CD8a1 DCs
poulos et al., 1994). However, mice homozygous for an but not the CD8a2 DCs in the spleen when transferred
Ikaros null mutation (C2/2, Ikaros C-terminus deletion) intravenously (Wu et al., 1996). Moreover, GM-CSF that
display less severe defects in their lymphoid lineages. promotes the in vitro development of myeloid-derived
These Ikaros null mice fail to generate both T and B DCs has a limited effect on the in vivo production of
lymphocytes during fetal hemopoiesis, but in the adult, DCs in lymphoid organs (Vremec et al., 1996). However,
although differentiation of B and NK cells is severely in vivo production of lymphoid organ DCs is greatly
impaired, some T cell development does take place stimulated by Flt3 ligand (Maraskovsky et al., 1996),
(Wang et al., 1996). In the postnatal Ikaros C2/2 thymus a which does promote thymic DC development in vitro.
few T cell precursors are found that undergo an aberrant In this investigation,we have used Ikaros mutant mice,
differentiation toward the CD4 lineage (Wang et al., which display selective defects in the lymphoid com-
1996). Differentiation along the erythroid and myeloid partments, to study the factors controlling DC develop-
ment and to explore the issue of their lineage origin. Welineages proceeds in both lines of Ikaros mutant mice
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find that the presence of both CD8a2 and CD8a1 DCs
in lymphoid organs is as dependent on Ikaros as is the
development of B and T lymphocytes. We also demon-
strate that the DC and lymphoid defects manifested in
the Ikaros mutant animals are stem cell autonomous
and not caused by the deficient microenvironment of a
lymphoid organ that is depleted of its lymphocytes.
Results
Ikaros DN2/2 Mice Lack Thymic and All
Splenic Dendritic Cells
The thymus and spleen of Ikaros DN2/2 mutant mice
were analyzed for their DC content. These mutant mice
lack LNs and therefore lack their DC populations (Geor-
gopoulos et al., 1994). Because the Ikaros DN2/2 rudi-
mentary thymus is so small and lacks lymphoid cells
(only a maximum of 1 3 105 cells could be obtained per
thymus), the usual DC pre-enrichment procedures were
omitted prior to analysis. However, the spleens of the
Ikaros DN2/2 mice were enlarged and filled with cells
of myeloid and erythroid origin; hence, pre-enrichment Figure 1. Lack of DCs in the Thymus and Spleen of Ikaros DN2/2
procedures were necessary prior to staining and analy- Mutant Mice
sis. Pooled Ikaros mutant thymuses were digested with Pooled (four to eight) thymuses orspleens from the wild-type control
mice and pooled spleens from Ikaros DN2/2 mutant mice were sub-collagenase, treated with EDTA, and then stained in
jected to dendritic cell extraction and enrichment procedures asthree colors with fluorochrome-conjugated antibodies
described in Experimental Procedures. The enriched dendritic cellagainst major histocompatibility complex (MHC) Class
preparations were stained in three fluorescent colors with FITC±
II, CD11c, and CD8a. The thymuses from wild-type lit- anti±MHC class II and PE±anti-CD8a and biotin anti-CD11c, then
termates and the spleens from both Ikaros mutant and Red-670±avidin as the second stage. Pooled (four to eight) thymuses
wild-type mice were subjected to the DC enrichment from Ikaros DN2/2 mice were digested with collagenase and treated
with EDTA, then stained with the same fluorescently labeled anti-procedures, then stained with the same antibodies. As
bodies as above. The stained cells were analyzed on the FACScan.shown in Figure 1 and Table 1, the MHC Class IIhi CD8a1
The fluorescence intensities are expressed on a four-decade loga-DC population normally present in the wild-type thymus
rithmic scale in all FACS profiles in this paper. Boxed DC populationswas missing from the Ikaros DN2/2 organ. This thymic
are shown as percentages of the events collected. The MHC ClassII1
DC deficiency was not surprising in view of our evidence DCs are also CD11c1 (data not shown).
that thymic DCs are lymphoid related and in view of
the complete lack of lymphocytes from this rudimentary
DN2/2 bone marrow were constructed. A minimal doseorgan. These thymuses also lacked any detectable level
of competing/supportive recipient type (homologous)of the common low CD4 T/DC precursor population
bone marrow was coinjected. The allelic forms of the(Georgopoulos et al., 1994; Wu, unpublished data).
common leukocyte antigen (Ly 5.1/Ly 5.2) were used toInterestingly, the spleens of the Ikaros mutant mice
distinguish between the progeny of donor bone marrowalso lacked DCs even though they were enlarged, and
and those of recipient or homologous bone marrow.they had an increase inmyeloid (Mac-11) cells compared
Preliminary studies on chimeric mice transferred withwith wild type (Figure 1; Table 1; Georgopoulos et al.,
different ratiosof Ikaros to homologousbone marrow cells1994). Both the MHC Class IIhi CD8a1 and the MHC
showed that the Ikaros DN2/2 mutant bone marrow cellsClass IIhi CD8a2 DC populations were absent from the
were not able to generate detectable levels of T cells inIkaros mutant spleens (Figure 1; Table 1). The absolute
the thymus and B cells in the spleen; however, theyDC numbers calculated to be present in Ikaros DN2/2
were able to generate Mac-11 myeloid cells in the spleenmutant thymus and spleen (Table 1) were equal to the
with a lower efficiency than Ikaros wild-type bone mar-background level, and no clear population with the MHC
row (see Table 2). These studies, and an independentClass IIhi CD8a1 phenotype was found (Figure 1). Analy-
sis of the Ikaros DN2/2 mutant mice for DCs was per-
formed on mice of two different genetic backgrounds, Table 1. Numbers of DCs in Thymus and Spleen of Ikaros DN1/1
C57BL/6 3 129 (Figure 1) and BALB/c 3 129 (data not and Ikaros DN2/2 Mice
shown), with similar results. DCs per Organ
Organs Ikaros DN1/1 Ikaros DN2/2
Ikaros DN2/2 Bone Marrow Cells Can Generate
Thymus 190 6 60 3 103 4 6 3 3 103Myeloid Lineage but Not Lymphoid
Spleen 390 6 10 3 103 8 6 2 3 103
Lineage Cells
Pooled tissues were enriched and analyzed for DC content as inTo test the differentiation potential of Ikaros DN2/2 he-
Figure 1. Results are the means 6 range of two experiments, eachmopoietic stem cells and their progenitors in a wild-type
involving a pool of five mice.
environment, chimeric mice with wild-type and Ikaros
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study on Ikaros-deficient hemopoietic stem cells and
progenitors, have established their lower frequency and
inherent lower competitive ability compared with the
wild-type hemopoietic stem cells (A. Nichogiannopou-
lou, unpublished data). It was determined that a 100-
fold excess of Ikaros DN2/2 over homologous marrow
was required for significant myeloid reconstitution in a
competitive assay. Accordingly, more refined experi-
ments were performed using bone marrow chimeras
generated by transferring 5 3 106 Ikaros mutant Ly 5.21
bone marrow cells together with 5 3 104 Ly 5.11 homolo-
gous bone marrow cells into lethally irradiated Ly 5.11
recipient mice. As controls, chimeras were also gener-
ated by transferring 5 3 106 wild-type Ly 5.21 bone
marrow cells together with 5 3 104 homologous Ly 5.11
bone marrow cells into Ly 5.11±irradiated recipients.
Recipient mice were analyzed for progeny cells 3±7
weeks later, a time frame that allows for development of
and reconstitution by donor-type hemopoietic lineages.
Over a 3- to 7-week period after transfer, wild-type
bone marrow cells were able to generate T cells (Ly
5.21CD41 and Ly 5.21Thy-11) in the thymus, and T cells
(Ly 5.21CD41 and Ly 5.21Thy-11), B cells (Ly 5.21B2201),
and myeloid cells (Ly 5.21Mac-11) in the spleen of the
recipient mice (Figure 2 and Table 2). However, even at
a 100-fold excess over homologous bone marrow, the
Ikaros mutant bone marrow cells still failed to produce
T and B lineage cells in either the thymus or the spleen,
although they generated myeloid cells in the spleen (Ly
5.21Mac-11, Figure 2, and Table 2). In contrast with
the limited differentiation potential of the Ly 5.21 Ikaros
DN2/2 bone marrow, the Ly 5.11 homologous bone mar-
row, although transferred at 100-fold lower amount, was
capable in the same mice of reconstituting both the T
and B lymphoid and myeloid lineages, thus providing
an internal control for the ability of the hemopoietic mi-
croenvironment to promote normal hemopoiesis in
these irradiated recipients (Ly 5.22 Lin1, Figure 2 and
Figure 2. Hemopoietic Lineage Development in the Bone Marrow
Table 2). Analysis of the bone marrow of these chimeras Chimeric Mice
gave similar results to those obtained from the spleen
The bone marrow chimeric mice were made by cotransferring intra-
(data not shown).Overall, the Ikaros DN2/2 bone marrow venously 5 3 104 host-type Ly 5.1 bone marrow cells together with
was incapable of forming lymphoid cells even when al- 5 3 106 Ikaros DN2/2 bone marrow or wild-type bone marrow cells
(Ly 5.2) into irradiated Ly 5.1 recipients (detailed in Experimentallowed to differentiate in a wild-type hemopoietic micro-
Procedures). Four weeks after transfer, the thymuses and spleensenvironment, thus confirming the cell-autonomous na-
from these chimeric mice were pooled, and single-cell suspensionsture of the Ikaros DN2/2 lymphoid and DC defects.
were stained with fluorescently labeled antibody against donor typeHowever, these Ikaros mutant hemopoietic populations
Ly 5.2 and with antibodies against different hemopoietic lineage
were capable of producing significant numbers of cells markers. Thymocytes were stained with FITC±anti±Ly 5.2 and PE±
of myeloid origin over the 3- to 5-week reconstitution anti-CD4. Spleen cells were stained with FITC±anti±Ly 5.2 and PE±
anti-CD4 for T cells, or FITC±anti±Ly 5.2 and PE±anti-B220 for Bperiod (Table 2). Given the short half-life of differentiated
cells, or FITC±anti±Ly 5.2 and biotin±anti-Mac-1 and followed withmyeloid cells (3±5 days), these must originate from the
Red-670±avidin as the second stage for myeloid cells. The percent-most primitive hemopoietic stem cell/progenitor com-
ages of Ly 5.2 donor-derived T cell, B cell, and macrophage arepartment.
indicated in the upper right quadrants.
myeloid cells by the cotransferred homologous boneIkaros DN2/2 Bone Marrow Cells Are Incapable
of Generating Dendritic Cells marrow (Figure 2, Ly 5.22; Table 2). Therefore the hemo-
poietic microenvironment in the recipient animals allowsTo determine whether the lack of DCs in the thymus
and spleen of the Ikaros DN2/2 mice was due to an for normal hemopoiesis to occur, and normal T cells
were available in these mice for interaction with DCs orintrinsic defect at the level of a DC progenitor, or due to
the absence of lymphocytes that can provide cytokines promotion of their development. Four weeks after bone
marrow transfer, pooled thymuses, spleens, and LNsnecessary for their development, we analyzed the bone
marrow chimeras for their DC content. These mice were were subjected to DC extraction and enrichment proce-
dures and analyzed for their DC content. As shown inreadily reconstituted with both T and B lymphoid and
Immunity
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Figure 3. Dendritic Cell Development in the Ikaros DN2/2 Bone Mar-
row Chimeras
The bone marrow chimeric mice described in Figure 2 were also
analyzed for DC development 4 weeks after transfer. Pooled thy-
muses, spleens, and LNs from the recipient mice were subjected
to DC extraction and enrichment procedures. The DC-enriched
preparations were stained in two fluorescent colors with FITC-conju-
gated anti-donor type Ly 5.2 together with biotinylated anti-MHC
class II, followed by Red-670±avidin as the second stage. The per-
centages of Ly 5.2 donor-derived DCs are indicated in the upper
right quadrants.
Figure 3, DCs in the lymphoid organs of wild-type bone
marrow chimeras were entirely of donor origin (Ly 5.21,
MHC Class IIhi ) indicating that the irradiation protocol
created enough space for the engraftment and develop-
ment of donor-type DCs within the time frame of these
reconstitutions. Ikaros DN2/2 bone marrow, on the other
hand, failed to generate detectable levels of DCs in the
thymus, spleen, and LNs (Figure 3). This deficit occurred
despite a DC reconstitution observed in these same
lymphoid organs by the Ly 5.11±homologous marrow
(Figure 3, Ly 5.22, MHC Class IIhi ), which demonstrates
that all the environmental factors required for DC devel-
opment were present. Note that virtually all of these Ly
5.22 DCs had been regenerated from the transferred
support bone marrow, since DC survival in the irradiated
host at this time point was negligible. Despite this inabil-
ity to generate DCs, the Ikaros DN2/2 bone marrow was
capable of generating myeloid (Mac-11) cells in periph-
eral lymphoid tissues (Figure 2, Mac-11/Ly 5.21).
In addition to the lymphoid and DC defects manifested
in Ikaros mutant mice, these animals also lack all their
peripheral lymphatic centers. This lack of peripheral lym-
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phatic centers in the Ikaros mutant mice prevented us
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from evaluating the ability of mutant hemopoietic pro- compartment in the spleen (Table 3). In contrast with wild-
type bone marrow, IkarosDN2/2 marrow gave no lymphoidgenitors to produce LN DCs that may be different in
origin and possibly functional and molecular makeup to cells in either the thymus or the spleen (Table 3).
DC production in the thymus and spleen of thesethe ones encountered in the spleen and thymus. How-
ever, the bone marrow chimeras provided us with the recipient mice was also determined. No Ikaros DN2/2
bone marrow±derived DCs were detected in the recipi-opportunity to analyze DC development from the Ikaros
mutant hemopoietic progenitors in an already formed ent thymus or spleen during the 4- to 5-week period
(Table 3), despite the generation of a significant numberLN structure. Even though wild-type bone marrow pro-
genitors produced DCs in these LNs, the Ikaros mutant of myeloid cells by the mutant donor bone marrow. In
sharp contrast, wild-type bone marrow reconstitutionsbone marrow progenitors were incapable of so doing
(Figure 3). produced significant numbers of thymic and splenic
DCs (Table 3).Taken together, these results demonstrate that the
failure of Ikaros DN2/2 bone marrow to generate DCs
and lymphocytes is an intrinsic defect of the mutant Dendritic Cells of the CD8a1 Type Are Found
at Low Levels in Ikaros C2/2 Micehemopoietic progenitor compartment, which is never-
theless capable of giving rise to myelomonocytes and Given the severe defect in the development of all
lymphoid and DC populations (CD8a1 and CD8a2) inmacrophages either in the intact Ikaros DN2/2 animals
or in the bone marrow reconstitution assays. the Ikaros DN2/2 mice, which suggested that Ikaros and
interacting factors are essential for their production, we
tested for DC production in the Ikaros null (C2/2) mice,
The Spleen of Ikaros DN2/2 Mice Does Not which display more selective defects in their B versus
Contain Cells Capable of Generating T lymphoid lineages. We found that in the thymus of
Lymphoid and Dendritic Cells adult Ikaros C2/2 null mice, which have on average 2-
The hypocellular bone marrow and the enlarged spleen to 5-fold lower cellularity, cells with the characteristics
of the Ikaros DN2/2 mice indicated that extramedullary of thymic DCs (high forward and side scatter,MHC Class
hemopoiesis is taking place in the spleen (Georgopoulos IIhiCD11c1CD8a1DEC-2051) were detected after a DC
et al., 1994). Therefore the spleen in the Ikaros DN2/2 enrichment procedure (Figure 4). However, a 15-fold
mice might have been the major source of hemopoi- reduction in DC numbers was found compared with
etic stem cells and progenitors capable of producing wild-type, which was greater than the 2- to 5-fold reduc-
lymphoid cells and DCs when transferred into a wild- tion seen in the number of thymocytes in the C2/2 mutant
type microenvironment. To test this hypothesis, up to 2 3 organ (Wang et al., 1996; Table 4).
107 splenocytes from Ikaros DN2/2 and wild-type mice The spleens of these Ikaros C2/2 mutant mice were
were transferred intravenously together with 105 homol- also analyzed for DCs. As shown in Figure 4, DCs (MHC
ogous bone marrow cells into irradiated Ly 5.1 recipi- Class IIhiCD11c1) were also found in the spleens of these
ents. Donor-derived hemopoietic lineage reconstitution C2/2 mutant mice. However, only one of the two types
in the recipient animals was determined 4±5 weeks later. of DC normally seen in the mouse spleen (Vremec and
The hemopoietic lineage reconstitutions observed in Shortman, 1997) was present, namely the CD8a1 DEC-
these animals were very similar to those obtained from 2051 type, which is similar to thymic DCs. The CD8a2
the bone marrow chimeras (data not shown). The Ikaros DEC-2052 DC subset, present in the spleen of the wild-
DN2/2 splenocytes produced myeloid cells (Mac-11) but type mice, was absent from the Ikaros C2/2 mice (Figure
failed to generate any lymphocytes or any thymic or 4 and Table 4). Overall, the number of the splenic DCs
splenic DCs. in Ikaros C2/2 mice was 8-fold lower than in the wild-
type controls (Table 4), indicating that the actual level
even of the CD8a1DEC-2051 DCs was greatly reduced
The Inability of Ikaros DN2/2 Bone Marrow Cells in these Ikaros C2/2 mice.
to Generate Lymphoid and Dendritic To determine whether DCs found in Ikaros C2/2 mice
Cells Is Not Due to Competition were mature and functional, DC-like cells from the C2/2
with Wild-Type Precursors mutant thymus and spleen were FACS-sorted by gating
It was possible that the failure of Ikaros mutant stem for CD11c1 cells, their morphology was examined under
cells to generate lymphoid cells and DCs in the recipi- the microscope, and their capacity to stimulate alloge-
ents could be due to their inability to compete with neic T cells was determined. The sorted DC-like cells
the 100-fold lower number of cotransplanted wild-type exhibited typical mature DC morphology of an irregular
homologous bone marrow cells. Since production of shape with many dendrites and cytoplasmic processes
donor-derived (Mac-11 Ly 5.21 Ikaros DN2/2) myeloid (data not shown). The antigen-presenting capacity of
cells was not affected to such an extent, this could these DCs was tested by culture with allogeneic CD4 T
represent an exceptional competitive disadvantage of cells (Figure 5). The low numbers of the Ikaros C2/2
the lymphoid and DC mutant precursors compared with derived DCs stimulated a T cell proliferative response
their homologous wild-type counterparts. To test this but with an efficiency below that of wild-type DCs.
possibility, Ly 5.21 Ikaros DN2/2 bone marrow (5 3 106
cells) was transferred alone into irradiated Ly 5.11 recipi- Generation of Low Numbers of CD8a1 DCs
ents. These mice were analyzed 4±5 weeks later for their and T Cells by Ikaros C2/2 Bone Marrow
hemopoietic compartment. Ikaros DN2/2 and wild-type To determine whether the associated development of
CD8a1 DCs and T cells in the absence of CD8a2 DCsbone marrow supported reconstitution of the myeloid
Immunity
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Table 3. Hemopoietic Lineage and DC Production by Ikaros DN2/2 Bone Marrow Cells
Ly 5.21 Donor-Derived Cells per Organ
Day Bone Marrow T Cell per T Cell per B Cell per Macrophage DC per DC per
of Cells Transferred Thymus Spleen Spleen per Spleen Thymus Spleen
Assay (3 1026) (3 1026) (3 1026) (3 1026) (3 1026) (3 1023) (3 1023)
28 5 DN1/1 96 10 82 34 560 600
5 DN2/2 BG BG BG 24 BG BG
Bone marrow cells from Ikaros DN2/2 mutant mice (Ly 5.2) or Ikaros DN1/1 wild-type control mice (Ly 5.2) were transferred into irradiated (9.5
Gy) Ly 5.1 recipient mice. The organs of two to three recipients were pooled for analysis 28 days after transfer. The levels of residual Ly 5.22
DCs in recipient mice not receiving bone marrow were , 1 3 103 per thymus and , 2 3 103 per spleen.
BG, cell numbers were within the range of background levels.
and B cells was an inherent feature of the hemopoietic linked to the development of T cells, whereas the lack
of development of CD8a2DEC-2052 DCs is linked to thestem cells of Ikaros C2/2 mice, bone marrow from these
mice was used to reconstitute irradiated wild-type mice, lack of development of B and NK cells.
by using the Ly 5.2 marker to track cells of donor origin.
In these experiments, rather than cotransferring recipi- Discussion
ent-type bone marrow, a low irradiation dose was em-
ployed to allow a parallel, low level reconstitution by the Different lines of evidence support the existence of two
distinct DC lineages in mice, one derived from a myeloidsurviving recipient stem cells. As in the previous studies,
controls transferring wild-type Ly 5.2 bone marrow gave precursor and one derived from a lymphoid precursor.
Studies on the in vitro differentiation of DCs from boneeffective reconstitution of all hemopoietic lineages, in-
cluding CD8a2DEC-2052 and CD8a1DEC-2051 DCs. marrow and blood progenitors under the influence of
GM-CSF have provided convincing evidence for a my-The endogenous reconstitution by the Ly 5.1-derived
stem cells that survived irradiation produced T and B eloid lineage±derived population (Inaba et al., 1992;
Caux et al., 1992; Young et al., 1995; Caux and Bancher-lymphocytes, myeloid cells, and both CD8a2DEC-2052
and CD8a1DEC-2051 DCs (Table 5). The Ikaros C2/2 eau, 1996). Our previous studies indicate that thymic
DCs and perhaps the CD8a1DEC-2051 splenic DC sub-bone marrow produced myeloid cells, some T cells, and
some CD8a1DEC-2051 DCs, but no B cells and no population are lymphoid related (Ardavin et al., 1993;
Wuet al., 1996; Saunders et al., 1996). MicehomozygousCD8a2DEC-2052 DCs (Table 5). Thus, the selective de-
velopmental defects in the Ikaros C2/2 mice were inher- for a dominant negative (DN2/2) and a null mutation
(C2/2) in the Ikaros gene display distinct defects in theent to stem cells and not environmentally determined.
Thus, it appears that in the absence of a functional development of their lymphoid (Georgopoulos et al.,
1994; Wang et al., 1996) and DC lineages and provideIkaros gene, the generation of CD8a1DEC-2051 DCs is
Figure 4. The Presence of Low Levels of CD8a1DEC-2051 DCs in the Thymus and Spleen, and the Absence of CD8a2DEC-2052 DCs in the
Spleen of Ikaros Null C2/2 Mice
Pooled (five to seven) thymuses or spleens from Ikaros C2/2 and wild-type siblings were subjected to DC extraction and enrichment procedures.
The DC-enriched cell preparations were stained in three fluorescent colors with FITC±anti±MHC class II, PE±anti-CD8a, and biotin±anti-CD11c
or biotin±anti-DEC-205, followed with Red-670±avidin as the second stage. The phenotypes of DCs were analyzed by gating for MHC class
II1 cells. The expression of DC markers CD11c, CD8a, and DEC-205 on the gated MHC class II1 cells is represented by the solid lines in the
histograms. The broken lines represent the background staining with isotype-matched control rat immunoglobulin. The absolute cell numbers
of each DC population per thymus or per spleen are summarized in Table 5.
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Table 4. Comparison of Numbers of Hemopoietic Lineage Cells in the Thymus and Spleen of Ikaros C2/2 and Ikaros C1/1 Mice
Cell Number per Organ
DCs
Organs B Cells T Cells CD8a2 CD8a1 Macrophages
Thymus
Ikaros C1/1 ND 575 3 106 0 310 3 103 ND
Ikaros C2/2 ND 110 3 106 0 19 3 103 ND
Spleen
Ikaros C1/1 87 3 106 24 3 106 99 3 103 451 3 103 13 3 106
Ikaros C2/2 BG 5 3 106 BG 67 3 103 14 3 106
Pooled thymuses and spleens from four Ikaros C2/2 or C1/1 mice were analyzed for the content of different hemopoietic lineages. For T, B,
and macrophage cells, cell suspensions were stained with fluorochrome-labeled antibodies against Thy-1, B220, and Mac-1 and analyzed by
flow cytometry. For DC analysis, tissues were first subjected to DC extraction and enrichment procedures. The cell preparations were then
stained with fluorescent labeled anti-MHC Class II, CD11c, and CD8, and analyzed by flow cytometry as described in Figure 5.
BG, cell numbers were within the range of background levels (,1 3 106 for splenic B cells and 2 3 103 for CD8a2 splenic DCs).
ND, not analyzed.
us with new models of potential molecular or lineal rela- Given the importance of inductive interactions in the
tionships between DC subsets and T and B lympho- differentiation of many hemopoietic lineages, we tested
cytes. Ikaros-deficient mice had previously been found whether the DC defect observed in the Ikaros DN2/2
to have normal skin Langerhans cells (Georgopoulos et mice was merely due to the lack of a proper environment
al., 1994), so it seemed likely that some aspects of DC for their development, in particular a secondary effect
development, perhaps the myeloid-derived lineage, of the lack of T lymphocytes. Bone marrow chimeras
might be intact in these mutant animals. were created, and they demonstrated that even in a
The DC results we obtained with the Ikaros DN2/2 normal environment and in the presence of normal he-
mutant mice were more extreme than we had predicted. mopoietic and lymphoid lineage reconstitution from
In accordance with our previous findings that the major- wild-type stem cells, the Ikaros DN2/2 stem cells still
ity of thymic DCs are generated from an intrathymic failed to produce any DCs or any T or B lymphocytes.
lymphoid precursor population, there was a complete It was established that the same chimeric mice that
absence of DCs in the thymus of these mice. However, developed T cells and DCs from the cotransferred nor-
the complete lack of DC subpopulations in the spleen mal bone marrow failed to develop any DCs or lymphoid
of the Ikaros DN2/2 mice, both in terms of the putative cells from the mutant bone marrow. Despite the absence
lymphoid-derived CD8a1DEC-2051 DCs and the puta- of DC development, the Ikaros DN2/2 bone marrow did,
tive myeloid-derived CD8a2DEC-2052 DCs, was a sur- however, generate monocytes and macrophages within
prising finding. This suggests either that the Ikaros gene the time frame of these lineage reconstitution assays.
family is independently essential for the complete devel- We therefore conclude that the failure of Ikaros DN2/2
opment of the myeloid-derived as well as the lymphoid- stem cells to produce either lymphocytes or DCs is a
related DCs or that the proportion of DCs that are cell-autonomous event and not the consequence of an
lymphoid-derived is far greater than we predicted. altered environment or lack of T lymphocytes.
Since Langerhans cells are present in the Ikaros DN2/2
mice (Georgopoulos et al., 1994) and these cells are
thought to migrate to LNsand constitute the interdigitat-
ing DCs in this tissue (Steinman, 1991), LNs seemed the
most likely site to study myeloid-derived DCs. However,
the Ikaros DN2/2 mutant mice lack peripheral lymphoid
centers, which may be a secondary consequence of the
lack of lymphoid or dendritic cells during fetal life. The
lack of LN structure in these mice may have prevented
the appropriate migration of Langerhans cells. However,
the bone marrow chimeric mice do have LNs, where
only DCs derived from wild-type but not from Ikaros
DN2/2 stem cells were found. This indicates that the
lack of DCs in the LNs of the chimeras is intrinsic to theFigure 5. The T Cell Stimulatory Activity of DCs from Ikaros C2/2
Ikaros mutant hemopoietic progenitors. The defect mayMutant Mice
be manifested both at the level of production of DCsThe thymic DCs from Ikaros C2/2 mutant (closed circles) or Ikaros
C1/1 wild-type mice (open circles) were enriched, then purified by (commitment and maturation) or at the level of their
FACS sorting for CD11c1 cells. Various numbers of DCs were cul- subsequent migration into the LN structures.
tured with 20,000 purified C3H CD4 T cells. A 16-hr pulse of 3H-TdR Further clues to a potential relationship between sub-
was given at day 3 of culture and incorporated thymidine determined
sets of DC and B or T cell precursors come from miceby liquid scintillation counting, as a measure of CD4 T cell prolifera-
with an Ikaros null (C2/2) mutation (Wang et al., 1996).tion. The values represent the mean of triplicate cultures, with the
These mice lack B cells, NK cells, and LNs but do displayerror bar representing the range of counts from each group. Back-
ground incorporation in the absence of DCs was ,200 cpm. some delayed and limited T cell differentiation (Wang
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et al., 1996). In addition to T cells, the adult Ikaros C2/2
mice also have a limited number of DCs in the thymus
and in the spleen. However, the DCs in the Ikaros C2/2
mice are all CD8a1DEC-2051. This is in contrast with
DCs in the wild-type spleen, where both CD8a1DEC-
2051 and CD8a2DEC-2052 DCs are found. We have
previously provided evidence that the thymic lymphoid
precursor generates only CD8a1DEC-2051 DCs in the
spleenof recipient mice (Wu et al.,1996), suggesting that
DCs of this phenotype are related to the T lymphocyte
lineage. These results further support the strong con-
nection between T cell and CD8a1DEC-2051 DC devel-
opment, in that a breakthrough in T cell development in
the Ikaros C2/2 mutant is accompanied by an equivalent
breakthrough in only the CD8a1DEC-2051 DC lineage.
It appears that the effects of the Ikaros mutations on
DC development are quite extensive and involve more
than just the putative T lymphoid±derived, CD8a1DEC-
2051 DCs. In the Ikaros dominant-negative homozy-
gotes, there is no evidence of Ikaros-independent DCs,
beyond the presence of Langerhans cells in the skin. It
is the CD8a1DEC-2051 DC population that shows our
predicted correlation between the effects of Ikaros on
T lymphocyte and DC development. The so-far putative
myeloid-derived, CD8a2DEC-2052 DCs are absent in
both strains of Ikaros mutant mice. This may be the
consequence of a defective differentiation of Ikaros-
deficient myeloid progenitors along the DC lineage, al-
though these are capable of giving rise to monocytes
and macrophages. Most importantly, the absence of
CD8a2DEC-2052 DCs manifested by both of the Ikaros
mutations indicates their similar molecular requirement
for differentiation as for the B and NK cell precursors.
A controversial lineal relationship between CD8a2DEC-
2052 DCs and B and NK cells is also a valid model for
testing.
Overall, this investigation demonstrates that Ikaros
and its gene family members are essential not only for
the development of lymphocytes but also for DCs. This
family of zinc-finger DNA-binding proteins, which is in-
volved at many different steps during hemopoiesis, is
required for the cell fate decisions of a pluripotent stem
cell or of a multipotent progenitor toward the lymphoid
and DC lineages. Further studies on the expression and
interaction of Ikaros gene family members in subsets of
DCs may reveal more on the molecular makeup of these
cells. A more precise molecular definition of DC subsets
in combination with in vitro and in vivo studies on the
developmental potential of Ikaros-deficient hemopoietic
progenitors toward the DC lineages may ultimately yield
valuable information on their origin, molecular controls
during differentiation, and specialized immune function.
Experimental Procedures
Mice
Ikaros DN and C-terminal deletion mutant mice (Ikaros DN2/2 and
C2/2), developed by the Georgopoulos laboratory on both the
C57BL/6 3 129 and BALB/c 3 129 backgrounds, were bred in the
virus-free animal facility of the Cutaneous Biology Research Center
at Massachusetts General Hospital (Georgopoulos et al., 1994;
Wang et al., 1996). For bone marrow transfer experiments, Ikaros
DN2/2 C57BL/6 (Ly 5.2) mice were used as bone marrow donors,
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their wild-type siblings were used as control donors, and C57BL/6
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Ly 5.1-Pep3b mice were used as recipients and as the source of the positive cells. In some experiments, in which only a limited number
of cells from the recipient thymuses or LNs were available, thehomologous bone marrow in constructing bone marrow chimeras.
All wild-type mice were obtained from The Jackson Laboratory (Bar tissues were digested with collagenase and treated with EDTA; then
the light density cells were collected. The immunomagnetic beadHarbor, ME).
depletion procedure was omitted. The cells were then stained by
the same procedures described above. The presence of Ikaros boneMonoclonal Antibodies and Fluorescent Reagents
marrow±derived (Ly 5.21) cells bearing markers for T cells (Thy-1),The monoclonal antibodiesand hybridoma clones used for depletion
B cells (B220), or myeloid cells (Mac-1) was determined by two-and for immunofluorescent labeling, the fluorochromes employed,
or three-color immunofluorescent staining on fresh, nonenrichedand thefluorescent reagents usedare all specified elsewhere (Ismaili
suspensions of the recipient thymuses and spleens, using FITC±et al., 1996; Wu et al., 1995; Vremec et al., 1992). In brief, the fluores-
anti±Ly 5.2, PE-conjugated anti-Thy-1, and either biotinylated anti-cence-conjugated antibodies used for DCstainings were fluorescein
B220 or biotinylated anti-Mac-1, followed by Red-670±avidin as theisothiocyanate (FITC)-conjugated or biotinylated anti-MHC Class
second stage.II (clone M5/114), phycoerythrin (PE)-conjugated anti-CD8a (clone
53.6), biotinylated anti-CD11c (clone N418), with Red-670±avidin
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